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plenary address at the International Society for Pharmacoeco-
nomics and Outcomes Research (ISPOR) 19th Annual Meeting,
held in Montreal, QC, Canada, from May 31 to June 4, 2014 [1].
David submitted the article recently for publication in our
journal, but tragically, he passed away on May 13, 2015. There-
fore, out of respect, we are publishing his piece verbatim as
submitted and have produced this short editorial to complement
the publication of what might be one of David’s last articles.
The article explains why randomized controlled trials are neces-
sary and how David’s passion for these studies developed. For the
most signiﬁcant part of his outstanding career, David was a found-
ing member and chair of the Department of Clinical Epidemiology
and Biostatistics (CE&B) at McMaster University in Hamilton,
Ontario, Canada. CE&B was the ﬁrst clinical epidemiology depart-
ment in North America, an innovative department in an innovative
medical school and a hotbed of evidence-based medicine.
David was always supportive of health economics and encour-
aged the economists at McMaster to develop a critical appraisal
checklist on economic evaluation for a series of critical appraisal
guides being produced by CE&B to assist physicians and other health
professionals in judging the quality of published studies. This 10-
point checklist subsequently became the basis for a textbook—
coauthored by one of the authors of this editorial, Mike Drummond
—titled Methods for the Economic Evaluation of Health Care Programmes,
ﬁrst published in 1987 and now entering its fourth edition [2].
Months before the plenary presentation, the other author of
this editorial, Don Husereau, accompanied the author of an
upcoming book [3] to interview David at his home in Irish Lake,
Ontario, to understand more about the man and his philosophy.
Beyond David’s already impressive list of academic achieve-
ments, several interesting learnings emerged, that provided more
insight into his extraordinary way of thinking. His thoughts about
the role of research and mentorship 40 years ago are reﬂected in
many activities of ISPOR and its members today and also the
important role of our Society.
The ﬁrst and foremost learning was David’s concern that
health research should address the needs of the patient. Patient-
centeredness has received increased attention only recently,
despite its early beginnings in evidence-based medicine. David
showed a deep concern for patient experiences, communicating
with patients, and research that reﬂects outcomes that are
important to patients [4].
The second learning was David’s deep emphasis on educating
the next generation to create and use evidence to improve
patient health. He spoke at length on the notion that experts
must eventually step aside to allow new ideas to ﬂourish [5].
David believed his legacy was his inﬂuence on the nextarticle: http://dx.doi.org/10.1016/j.jval.2015.04.0generation of researchers and care providers, allowing them to
develop new methods and approaches.
The last was the importance of networks and multidisciplinary
collaboration, another important part of the mission of ISPOR. North
America’s increasing focus on efﬁciency and evidence in health care
grew in parallel in the United Kingdom (inﬂuenced by Archie
Cochrane and others), although no formal networks existed through
which to exchange ideas and develop consensus methods. David and
other pioneers in Canada, the United States, and the United Kingdom
created their own linkages, as a means of sharing ideas and
perspectives.
Knowing David and his work greatly enriched our lives. Our
main reﬂection on his passing is that, although many individuals
develop new methodologies, very few develop a whole new ﬁeld
of study and application with a strong underlying vision.
Michael Drummond, DPhil
University of York, York, North Yorkshire, UK
Don Husereau, MSc
Institute of Health Economics and University of Ottawa
Ottawa, Ontario, Canada
1098-3015/$36.00 – see front matter
Copyright & 2015, International Society for
Pharmacoeconomics and Outcomes Research (ISPOR).
Published by Elsevier Inc.
http://dx.doi.org/10.1016/j.jval.2015.06.001R E F E R E N C E S[1] Sackett D. Why did the RCT become the primary focus of my career?
Value Health 2015;18 xx-xx.
[2] Drummond MF, Sculpher MJ, Claxton K, et al. Methods for the Economic
Evaluation of Health Care Programmes (4th ed.) Oxford: Oxford
University Press, 2015.
[3] Cassels A. Medicine’s Best Kept Secret: The People and the Passion
behind the Cochrane Collaboration. Victoria, BC, Canada: Agio. 2015.
In press.
[4] Sackett DL, Spitzer WO, Gent M, Roberts RS. The Burlington randomized
trial of the nurse practitioner: health outcomes of patients. Ann Intern
Med 1974;80:137–42.
[5] Sackett DL. Second thoughts. Proposals for the health sciences–I:
compulsory retirement for experts. J Chronic Dis 1983;36:545–7.01
